Condensed Statements of Shareholders' Deficiency - USD ($)	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance (in shares)	1,899,575
Beginning balance	$ (1,153,602)	$ (1,035,129)
Net loss	$ (26,697)	(24,713)
Ending balance (in shares)	1,899,575
Ending balance	$ (1,180,299)	$ (1,059,842)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance (in shares)	1,899,575	1,899,575
Beginning balance	$ 1,900	$ 1,900
Ending balance (in shares)	1,899,575	1,899,575
Ending balance	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	8,418,684	8,418,684
Ending balance	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	(9,574,186)	(9,455,713)
Net loss	(26,697)	(24,713)
Ending balance	$ (9,600,883)	$ (9,480,426)